About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Portland | 9,757 Studies Near You

Clinical TrialsPortland

Clinical Trials in Portland

Discover 9,757 clinical trials near Portland, Oregon. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 5241-5260 of 9,757 trials

CompletedRasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's DiseaseTo assess the efficacy of rasagiline 1 mg as a first add-on treatment to dopamine agonist therapy in early Parkinson Disease (PD) patients, , not optimally controlled on dopamine…NCT01049984·Phoenix, Arizona and 57 others

Find Trials by Condition in Portland

Breast Cancerin Portland Lung Cancerin Portland Prostate Cancerin Portland Colorectal Cancerin Portland Melanomain Portland Leukemiain Portland Lymphomain Portland Pancreatic Cancerin Portland Ovarian Cancerin Portland Brain Cancerin Portland Diabetes

Data from ClinicalTrials.govTerms

CompletedUptitration Trial of Flibanserin Versus Placebo in Premenopausal Women With Hypoactive Sexual Desire DisorderThis trial is designed to assess the safety and efficacy of flibanserin in the treatment of premenopausal women with Hypoactive Sexual Desire Disorder (HSDD) that meets standard…NCT00360555·Birmingham, Alabama and 76 others

CompletedA Pivotal Open-Label Trial of Brentuximab Vedotin for Hodgkin LymphomaThis is a single-arm, open-label, multicenter, pivotal clinical trial to evaluate the efficacy and safety of brentuximab vedotin (SGN-35) as a single agent in patients with…NCT00848926·Birmingham, Alabama and 26 others

CompletedTralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 2 (ECZema TRAlokinumab Trial no. 2)Primary objective: To evaluate the efficacy of tralokinumab compared with placebo in treating moderate to severe atopic dermatitis (AD).NCT03160885·Hot Springs, Arkansas and 114 others

Active not recruitingOP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast CancerThis phase 3 clinical trial compares the safety and efficacy of palazestrant (OP-1250) to the standard-of-care options of fulvestrant or an aromatase inhibitor in women and men…NCT06016738·Tucson, Arizona and 232 others

UnknownA Study of the Functional Magnetic Resonance Imaging Response to Leptin and PramlintideThe purpose of this study is to identify how certain parts of the brain that help control body weight respond to an infusion of hormones called leptin and amylin.NCT00691158·Portland, Oregon

CompletedRituximab in Renal Allograft Recipients Who Develop Early De Novo Anti-HLA AlloantibodiesThe purpose of this study is to determine whether treatment with rituximab (anti-CD20, Rituxan®, MabThera®) in individuals who develop new anti-HLA antibodies after renal (kidney)…NCT00307125·Birmingham, Alabama and 16 others

CompletedSafety and Efficacy Study of AA4500 (XIAFLEX™, Proposed Name) in the Treatment of Advanced Dupuytren's DiseaseThis was a Phase 3, 9-month, open-label study conducted in the United States.NCT00528840·Phoenix, Arizona and 13 others

CompletedFirst-in-human Study of IO-108 as Single Agent and in Combination With a PD-1 Immune Check Point Inhibitor in Patients With Advanced Solid TumorsThe goal of the clinical trial is to learn about safety, tolerability and preliminary efficacy of IO-108 as monotherapy or in combination with a PD-1 inhibitor in patients with…NCT05054348·Tucson, Arizona and 23 others

CompletedCombination Chemotherapy With or Without Donor Bone Marrow Transplantation in Treating Infants With Previously Untreated Acute Lymphoblastic LeukemiaRATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die.NCT00022126·Phoenix, Arizona and 50 others

CompletedEfficacy of Dexlansoprazole MR on Heartburn Control in Participants Previously Receiving Twice Daily Proton Pump Inhibitor TherapyThe purpose of this study is to determine if patients with well-controlled heartburn symptoms on twice-daily proton pump inhibitor therapy remain well-controlled after stepping…NCT00847808·Hueytown, Alabama and 51 others

RecruitingPharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed InfantsOver half of women in the US who are breastfeeding their infants take prescription drugs.NCT03511118·La Jolla, California and 21 others

RecruitingImplementation of Problem-Solving Treatment in Community Health Centers (PST-Aid)Although evidence-based clinical interventions (CI) are a preferred treatment option for patients with depression, CIs are rarely available in community primary care settings.NCT06494384·Portland, Oregon

TerminatedDS-6157a in Participants With Advanced Gastrointestinal Stromal Tumor (GIST)This study will assess the safety, efficacy, and pharmacokinetics of DS-6157a in participants with advanced gastrointestinal stromal tumors (GIST).NCT04276415·Boston, Massachusetts and 4 others

CompletedS0030: Capecitabine in Treating Older Patients W/Metastatic or Recurrent Colorectal Cancer That Cannot Be Surgically RemovedRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00049335·Mobile, Alabama and 89 others

CompletedOlaparib and Durvalumab in Treating Participants With Metastatic Triple Negative Breast CancerThis pilot phase I trial studies whether it is feasible to conduct a detailed molecular profile of triple negative breast cancer as part of a treatment strategy that asks whether…NCT03544125·Portland, Oregon

RecruitingExtended vs Short-term Abatacept Dosing for Graft Versus Host Disease ProphylaxisThis is a multicenter randomized, double blind, Phase 2 trial for patients receiving transplants from 7 of 8 HLA matched donors, in which an extended dosing regimen of abatacept…NCT04380740·Duarte, California and 14 others

CompletedModel 4965 Post-Approval StudySafety and effectiveness will be summarized for the model 4965 lead. This study was conducted within Medtronic's System Longevity Study (SLS).NCT01076348·Birmingham, Alabama and 106 others

CompletedStudy of Lenvatinib (MK-7902/E7080) in Combination With Pembrolizumab (MK-3475) Versus Standard of Care in Participants With Metastatic Colorectal Cancer (MK-7902-017/E7080-G000-325/LEAP-017)The purpose of this study is to assess the safety and efficacy of lenvatinib (MK-7902/E7080) in combination with pembrolizumab (MK-3475) in participants with metastatic colorectal…NCT04776148·Monterey, California and 94 others

CompletedA Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Subjects With Active Axial Spondyloarthritis Including Ankylosing Spondylitis and Nonradiographic Axial SpondyloarthritisThe purpose of the study is to demonstrate the long-term safety, tolerability and efficacy of bimekizumab in patients with active axial spondyloarthritis (axSpA, also known as…NCT04436640·Glendale, Arizona and 74 others

PreviousPage 263 of 488Next

in Portland

Heart Diseasein Portland